Vitamin D Supplementation in Critically Ill Children With Respiratory Disease

Launched by ASSIUT UNIVERSITY · Aug 6, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how vitamin D supplementation might help critically ill children who have respiratory diseases, such as pneumonia or asthma. The goal is to see if giving these children extra vitamin D can improve their health outcomes while they are in the Pediatric Intensive Care Unit (PICU).

To participate in this study, children must be between 1 month and 16 years old and currently admitted to the PICU for respiratory issues. Unfortunately, children with other serious health problems that are not related to breathing will not be eligible. While the trial is not yet recruiting participants, families can expect that if their child is included, they will receive either vitamin D or a placebo (a substance with no active effect) during their treatment. This trial aims to provide valuable information that could help improve care for children with respiratory diseases in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All pediatric patients admitted in PICU with respiratory disease with age from 1month to 16 years.
• Exclusion Criteria:
• • Patients admitted in PICU due to causes rather than respiratory disease.